Who owns OCUPHIRE PHARMA INC?
- Ticker: OCUP
- CUSIP Number: 67577r102
Tip: Access positions for across all investors
Analyze quarterly positions in Ocuphire Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ocuphire Pharma stock
Who bought or sold OCUPHIRE PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 992k | $2.0M | 7% | Mar 2024 |
|
| Rice Hall James & Associates | 292k | $587k | -49% | Mar 2024 |
|
| Geode Capital Management | 234k | $471k | 7% | Mar 2024 |
|
| Richmond Brothers | 228k | $457k | -10% | Mar 2024 |
|
| MAI Wealth Advisors | 224k | $450k | -43% | Mar 2024 |
|
| Bridgeway Capital Management | 210k | $422k | 406% | Mar 2024 |
|
| Knoll Capital Management | 100k | $201k | 0% | Mar 2024 |
|
| BlackRock | 97k | $194k | 4% | Mar 2024 |
|
| Citadel Advisors | 89k | $180k | 214% | Mar 2024 |
|
| American Century Companies | 66k | $133k | 9% | Mar 2024 |
|
| Morgan Stanley | 56k | $113k | 91% | Mar 2024 |
|
| Northern Trust | 52k | $104k | 68% | Mar 2024 |
|
| Diametric Capital | 51k | $103k | -8% | Mar 2024 |
|
| Susquehanna International | 43k | $86k | -24% | Mar 2024 |
|
| Kestra Private Wealth Services | 42k | $85k | 0% | Mar 2024 |
|
| Mackenzie Financial | 41k | $82k | 100% | Mar 2024 |
|
| Millennium Management | 37k | $74k | -57% | Mar 2024 |
|
| Empowered Funds | 37k | $74k | 100% | Mar 2024 |
|
| William Blair $ Company | 33k | $67k | 0% | Mar 2024 |
|
| Trust Co Of Toledo Na | 31k | $62k | 0% | Mar 2024 |
|
| Brian McDonald | 30k | $60k | 0% | Mar 2024 |
|
| Springbok Capital Management | 21k | $41k | 15% | Mar 2024 |
|
| Hrt Financial | 20k | $39k | 100% | Mar 2024 |
|
| Captrust Financial Advisors | 18k | $36k | 0% | Mar 2024 |
|
| Virtu Financial | 18k | $36k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 17k | $33k | -5% | Mar 2024 |
|
| Bedel Financial Consulting | 15k | $30k | 0% | Mar 2024 |
|
| UBS Group | 14k | $29k | 164% | Mar 2024 |
|
| Stokes Family Office | 12k | $24k | 0% | Mar 2024 |
|
| Lincoln National | 12k | $24k | 2% | Mar 2024 |
|
| Summit Trail Advisors | 11k | $21k | 100% | Mar 2024 |
|
| Tower Research Capital | 7.4k | $15k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 3.0k | $6.0k | 1% | Mar 2024 |
|
| Simplex Trading | 2.1k | $4.0k | -79% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 2.0k | $6.1k | 0% | Dec 2023 |
|
| Proequities | 1.2k | $2.4M | 0% | Mar 2024 |
|
| Toth Financial Advisory Corporation | 1.0k | $2.0k | 0% | Mar 2024 |
|
| Optimum Investment Advisors | 1.0k | $2.0k | 0% | Mar 2024 |
|
| CarsonAllaria Wealth Management | 1.0k | $2.0k | 0% | Mar 2024 |
|
| Nbc Securities | 600.00 | $1.0k | 0% | Mar 2024 |
|
| Old Point Trust & Financial Services N A | 500.00 | $1.0k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 29.00 | $58.000000 | 0% | Mar 2024 |
|
| ICA Group Wealth Management | 10.00 | $20.000000 | -67% | Mar 2024 |
|
| Royal Bank of Canada | 5.00 | $0 | -100% | Mar 2024 |
|
| FSA Wealth Management | 5.00 | $10.000000 | 0% | Mar 2024 |
|
Who sold out of Ocuphire Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squarepoint Ops | Dec 2023 | 61k | $184k |
| Acadian Asset Management | Sep 2023 | 50k | $165k |
| Victory Capital Management | Dec 2023 | 47k | $141k |
| Jane Street | Dec 2023 | 35k | $104k |
| LPL Financial | Sep 2023 | 33k | $110k |
| United Bank | Dec 2023 | 12k | $36k |
| Group One Trading | Sep 2023 | 2.3k | $7.7k |
| Bank of America Corporation | Dec 2023 | 27.00 | $81.000000 |